News & Alerts
-
Dec- 2023 -28 December
FDA Updates Guidance on Topical Ophthalmic Drug Quality
In a significant development for the pharmaceutical industry, the U.S. Food and Drug Administration (FDA) has made an announcement regarding…
Read More » -
28 December
Jemincare’s Wholly Owned Subsidiary Secures 6 Clinical Trial Approvals for Innovative Drugs
Jemincare, a prominent Chinese pharmaceutical company, has announced significant progress in its drug development endeavors. Its wholly-owned subsidiary, Shanghai Jemincare…
Read More » -
28 December
Innovent Biologics and Sanegene Bio to Collaborate on Innovative siRNA Drug for Hypertension Treatment
Innovent Biologics, a prominent biopharmaceutical company, and Sanegene Bio USA have announced a strategic collaboration to co-develop SGB-3908, an siRNA…
Read More » -
28 December
Everest Medicines’ Nefecon® Advances Toward Approval for IgA Nephropathy Treatment in Taiwan
Shanghai-based biopharmaceutical company Everest Medicines has announced that its New Drug Application (NDA) for Nefecon® has been accepted for review…
Read More » -
28 December
Lead Poisoning Nightmare: Tainted Fruit Puree Pouches Cause 251 Cases Across 34 States
A startling surge in lead poisoning cases linked to contaminated fruit puree pouches has reached a staggering 251 reported cases…
Read More » -
28 December
FDA Issues New Guidance to Tackle Benzene Levels in Drug Products
In a significant move, the U.S. Food and Drug Administration (FDA) has issued new guidance aimed at aiding drug manufacturers…
Read More » -
27 December
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene
Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), has initiated a voluntary recall of one lot of Americaine® 20%…
Read More » -
27 December
Pfizer’s Hospira, Inc. Initiates Voluntary Recall of Bleomycin for Injection Due to Glass Particulate Contamination
Pfizer’s Hospira, Inc., a leading pharmaceutical company, has issued a voluntary recall of one lot of Bleomycin for Injection, USP…
Read More » -
23 December
Generic Drugmaker Stada has Spun off Russian Business
In recent news, the generic drugmaker Stada has reportedly separated its Russian business, establishing a distinct entity named Nizhpharm, as…
Read More » -
22 December
Use of Unapproved Fat-Dissolving Injections Poses Serious Health Risks FDA Warns
In a recent announcement, the Food and Drug Administration (FDA) has issued a stern warning about the potential dangers associated…
Read More »